Anti-HIF3 alpha/IPAS antibody
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Polyclonal HIF3 alpha/IPAS antibody. Suitable for WB and reacts with Rat samples. Cited in 2 publications. Immunogen corresponding to Synthetic Peptide within Human HIF3A aa 450-550.
View Alternative Names
BHLHE17, MOP7, PASD7, HIF3A, Hypoxia-inducible factor 3-alpha, HIF-3-alpha, HIF3-alpha, Basic-helix-loop-helix-PAS protein MOP7, Class E basic helix-loop-helix protein 17, HIF3-alpha-1, Inhibitory PAS domain protein, Member of PAS protein 7, PAS domain-containing protein 7, bHLHe17, IPAS
- WB
Supplier Data
Western blot - Anti-HIF3 alpha/IPAS antibody (AB176464)
All lanes:
Western blot - Anti-HIF3 alpha/IPAS antibody (ab176464) at 0.1 µg/mL
All lanes:
Rat brain tissue lysate
Predicted band size: 72 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HIF3 alpha engages in cellular response to hypoxic environments by binding to hypoxia-responsive elements in DNA. It forms heterodimers with ARNT an aryl hydrocarbon receptor nuclear translocator allowing interaction with DNA sequences needed for hypoxia response. HIF3 alpha differs by sometimes inhibiting rather than activating target genes providing a balance to the functions of other HIFs. It affects vascular development and energy metabolism performing roles outside traditional hypoxia response.
Pathways
HIF3 alpha integrates into key biological networks such as the HIF signaling pathway and oxygen homeostasis. Within these pathways it interacts with other HIF family members including HIF1 alpha and HIF2 alpha regulating downstream hypoxia-adaptive responses. This interaction allows a fine-tuned balance in the expression of genes linked to angiogenesis and erythropoiesis exemplifying its antagonistic function in comparison to other HIFs that usually activate these pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
British journal of cancer 130:1904-1915 PubMed38693428
2024
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medic 2019:2807926 PubMed30941190
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com